原肌球蛋白受体激酶A
trk受体
癌症研究
肿瘤进展
神经生长因子
内科学
内分泌学
蛋白激酶B
结直肠癌
PI3K/AKT/mTOR通路
医学
生物
癌症
信号转导
受体
细胞生物学
作者
Hiroki Kobayashi,Tadashi Iida,Y. Ochiai,Ermanno Malagola,Xiaofei Zhi,Ruth A. White,Jin Qian,Feijing Wu,Quin T. Waterbury,Ru‐Hong Tu,Biyun Zheng,Jonathan S. LaBella,Leah Zamechek,Atsushi Ogura,Susan L. Woods,Daniel L. Worthley,Atsushi Enomoto,Timothy C. Wang
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2024-08-13
标识
DOI:10.1158/2159-8290.cd-24-0287
摘要
Abstract Cancer-associated fibroblasts (CAFs) and nerves, components of the tumor microenvironment, have each been shown to directly promote gastrointestinal cancers. However, it remains unknown whether these cells interact with each other to regulate cancer progression. We found that in colorectal cancer (CRC) norepinephrine induces ADRB2-dependent nerve growth factor (NGF) secretion from CAFs, which in turn increases intra-tumor sympathetic innervation and norepinephrine accumulation. Adrenergic stimulation accelerates CRC growth through ADRA2A/Gi-mediated activation of Yes-Associated Protein (YAP). NGF from CAFs directly enhances CRC cell growth via the PI3K/AKT pathway. Treatment with a tropomyosin receptor kinase (Trk) inhibitor decreased YAP and AKT activation and CRC progression in mice. In human CRC, high NGF expression is associated with the mesenchymal-like tumor subtype and poor patient survival. These findings suggest a central role for reciprocal CAF-nerve crosstalk in promoting CRC progression. Blocking this feedforward loop with a Trk inhibitor may represent a potential therapeutic approach for CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI